Clinical Drug Investigation

Acknowledgement

Triptorelin 6-Month Formulation in the Management of Patients with Locally Advanced and Metastatic Prostate Cancer

Eija A. Lundström, Rupert K. Rencken, Johann H. van Wyk, Lance J.E. Coetzee, Johann C.M. Bahlmann, Simon Reif, Erdam A. Strasheim, Martin C. Bigalke, Alan R. Pontin, Louis Goedhals, Douw G. Steyn, Chris F. Heyns, Luigi A. Aldera, Thomas M. Mackenzie, Daniela Purcea, Pierre Y. Grosgurin, Hervé C. Porchet

Antihypertensive Efficacy of Perindopril 5–10 mg/day in Primary Health Care

Dan-Dominic Ionescu

Subjective Effects and Safety of Whole and Tampered Morphine Sulfate and Naltrexone Hydrochloride (ALO-01) Extended-Release Capsules versus Morphine Solution and Placebo in Experienced Non-Dependent Opioid Users

Joseph Stauffer, Beatrice Setnik, Marta Sokolowska, Myroslava Romach, Franklin Johnson, Edward Sellers

The Role of Baseline Blood Pressure in Guiding Treatment Choice

James L. Pool, Robert Glazer, Nora Crikelair, Drew Levy

Patient Satisfaction with Switching to Esomeprazole from Existing Proton Pump Inhibitor Therapy for Gastro-Oesophageal Reflux Disease

Robert J. Hoogendoorn, Lex Groeneveld, J. Andy Kwee

Effect on the Atherogenic Marker Plasminogen Activator Inhibitor Type-1 of Addition of the ACE Inhibitor Imidapril to Angiotensin II Type 1 Receptor Antagonist Therapy in Hypertensive Patients with Abnormal Glucose Metabolism

Ken Yajima, Akira Shimada, Hiroshi Hirose, Yoichi Oikawa, Satoru Yamada, Shu Meguro, Junichiro Irie, Seiko Irie

Abdominal Aortitis after Use of Granulocyte Colony-Stimulating Factor

Giridhar U. Adiga, Dahlia Elkadi, Sandeep K. Malik, Jill D. Fitzpatrick, Stefan Madajewicz